课题基金 / 基金详情

Anticancer drug-Induced Fas (CD95)-dependent Apoptosis of Human Tongue Carcinoma

Anticancer drug-Induced Fas (CD95)-dependent Apoptosis of Human Tongue Carcinoma
抗癌药物诱导的Fas(CD95)依赖性人舌癌细胞凋亡
批准号:
10671766
负责人:
MISHIMA Koichi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MISHIMA Koichi的其他基金

相似基金

相关文献

中文摘要
翻译
我们通过观察舌癌的细胞凋亡和抗癌药物的作用,发现在舌癌中介导细胞凋亡级联反应的分子。卡铂(CBDCA)、培霉素和甲氨蝶呤可诱导人高分化舌鳞癌SCC-25细胞凋亡。中和的抗fas和抗fas配体(FasL)抗体消除了cbdca诱导的细胞死亡,通过DNA片段测量和相衬显微镜观察进行了检测。在缺乏CBDCA的情况下,与细胞表面Fas结合并激活Fas的细胞毒性抗Fas抗体未能诱导细胞凋亡。然而,细胞毒性抗体以剂量依赖的方式显著增强cbdca诱导的细胞凋亡。Western blotting和反转录PCR显示,CBDCA处理后,Fas和FasL的表达没有变化。SCC-25诱导fas敏感t淋巴白血病Jurkat细胞凋亡。这些结果表明,舌癌细胞表达非功能性Fas和功能性Fas配体,它们本身不能诱导细胞凋亡,CBDCA处理将非功能性Fas转换为功能性Fas,激活Fas敏感通路导致细胞凋亡。
英文摘要
We examined the apoptosis of tongue carcinoma and the effects of anticancer drugs to identify the molecules that mediate apoptotic cascade in the malignancy. Carboplatin (CBDCA), peplomycin and methotrexate induced apoptosis of SCC-25, human well-differentiated tongue squamous carcinoma cell line, as detected by measurement of DNA fragmentation. Neutralizing anti-Fas and anti-Fas ligand (FasL) antibodies obliterated the CBDCA-induced cell death, examined by both measurement of DNA fragmentation and phase-contrast microscopic observation. In the absence of CBDCA, cytotoxic anti-Fas antibody, which binds to and activates Fas at the cell surface, failed to induce the apoptosis. However, the cytotoxic antibody markedly enhanced the CBDCA-induced apoptosis in a dose-dependent manner.Western blotting and reverse-transcript PCR revealed that there were no alterations in Fas or FasL expression upon CBDCA treatment. SCC-25 induced apoptosis of Jurkat cells, Fas-sensitive T-lymphatic leukemia cell line. These results indicate that the tongue carcinoma cells express nonfunctional Fas and functional Fas ligand, which by themselves fail to induce apoptosis, and that CBDCA treatment switches nonfunctional Fas to functional Fas, activating a Fas sensitive pathway leading to apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of TGF-beta type 1 receptor inhibitor on choloidal neovascularization
  • 批准号:
    19791257
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.42万
  • 财政年份:
    2007
  • 负责人:
    MISHIMA Koichi
  • 依托单位:
国内基金
海外基金
基于WTAP/METTL3-KRT8-FAS轴探讨卵巢子宫内膜样癌预后及化疗敏感性的临床研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    章杰捷
  • 依托单位:
基于Fas/Fas-L 信号通路探讨肾小管上皮细胞外泌体对椎间 盘退变的影响及补肾活血汤干预机制
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
  • 批准号:
    32360836
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    张全伟
  • 依托单位:
土家药血筒中血筒素抗RA药效及Fas/caspase-8/-3通路介导滑膜细胞凋亡机制研究
  • 批准号:
    2023JJ40490
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    余黄合
  • 依托单位: